NexgenRx Inc (TSE:NXG) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
NexgenRx Inc. reported a robust first quarter in 2024, showcasing a 24% increase in revenue to $4.3 million and substantial growth in net income and EBITDA, attributed to the successful introduction of SaaS solutions and a strong sales pipeline. The company celebrated its 20th anniversary with a record Q1 performance and a solid cash position, even after a significant dividend payout to shareholders.
For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.
